A pharmacokinetic model for ocular drug delivery

Area of Science:

• Pharmacokinetics
• Ocular Drug Delivery
• Biomedical Modeling

Background:

• Understanding ocular drug pharmacokinetics is crucial for effective treatment.
• Existing models may not fully capture complex drug distribution within the eye.

Purpose of the Study:

• To develop and validate a pharmacokinetic model for ocular drug delivery.
• To predict drug concentration profiles in various eye tissues.

Main Methods:

• Developed a pharmacokinetic model based on Fick's second law of diffusion.
• Utilized in vitro membrane penetration experiments to evaluate model parameters.
• Validated the model against in vivo concentration data.

Main Results:

• The model accurately predicts drug concentration in the aqueous humor, vitreous body, and other eye tissues.
• Successfully described drug distribution following both topical and systemic administration.
• Incorporated factors like drug binding, metabolism, and individual ocular variations.

Conclusions:

• The developed ocular pharmacokinetic model provides a robust tool for predicting drug behavior in the eye.
• The model can simulate the impact of physiological and pathological conditions on drug distribution.
• This model aids in optimizing ocular drug delivery strategies.